Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. Additionally, severe side effects, including cardiovascular events and pneumonia, were considered improbable consequences of medicinal cannabis usage.

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

SEPTEMBER 22, 2021

Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Phase 1 clinical trials are scheduled for Q3 2022 with Phase 2 trials expected in Q2 2023. The principal objective of Programme 3 is to identify a drug candidate(s) for neuropathic pain conditions. the CBD, CBG or THC compounds).

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Veriheal

AUGUST 21, 2023

On June 22, 2023, Mets owner Steve Cohen and his wife made headlines with his remarkable donation of $5 million donated to the Multidisciplinary Association for Psychedelic Studies (MAPS). The $5 million donation will assist the fund, providing financial assistance to individuals needing access to MDMA therapy.

Therapy 90

Therapy Research and Development Treatment Environment 90

Canna Law Blog

JULY 14, 2023

On July 5, 2023, the FDA and FTC jointly announced six cease and desist letters to alleged delta-8 product makers. You can access the letters here. Unlike prior rounds of warning letters, these letters have a new focus: harm to children. Ingesting edible cannabis products can result in serious health consequences in children.3

Packaging 77

Packaging Food Edibles THC 77

Cannabis Law Report

DECEMBER 8, 2021

It emerges from the 2018-2023 coalition agreement that legislation on recreational cannabis will be drafted ( 2018-2023 Coalition Agreement ) . Provision should be made for the plants to be in any event not visible to anyone passing by on the public highway. Source: [link]. community gardens). community gardens).

Recreational 52

Recreational Seed-To-Sale Consumption Events 52

Cannabis Law Report

JUNE 28, 2021

Merger includes retail, distribution and cultivation capabilities in the limited license market where adult-use sales are expected to reach up to US$230 million in 2023[1]. Retail sales in Vermont for adult-use cannabis products are expected to begin in the fall of 2022, with sales expected to reach up to US$230 million in 2023.

Retail 59

Retail Dispensary Packaging History 59

Cannabis Law Report

AUGUST 16, 2021

The facility is expected to be operational in Q1 2023. Once closed, which will be subject to the execution of definitive agreements and satisfaction of regulatory and other conditions, management believes this acquisition would solidify the Company’s scaled position in this core market and would be accretive to EBITDA. Massachusetts.

Business 105

Business Dispensary Retail Cultivation 105

Cannabis Law Report

FEBRUARY 16, 2022

Final approval for listing of the Jones Shares on the CSE will be subject to Jones fulfilling certain standard conditions of the CSE set out in its conditional acceptance letter. Listing on the Canadian Securities Exchange. The Contingent Convertible Debentures are convertible into units of Jones at a conversion price of US$0.50

Events 52

Events Conditions Edibles Business 52

Cannabis Law Report

DECEMBER 21, 2021

(“Laurentian”), in a cash and share transaction for aggregate consideration of $36 million, plus earnout consideration (the “Earnout Consideration”) payable, if applicable, based on Laurentian surpassing certain EBITDA thresholds in calendar 2022 and 2023. million expected to be included as an adjustment in 2022 and $3.5 million in 2022.

Hash 52

Hash Events Cultivation Business 52

Illinois News Joint

MARCH 11, 2024

MCAB board members took preliminary votes to include two qualifying debilitating conditions for medical cannabis patients in Illinois. After public comment, board members voted anonymously via private messages for two new conditions to be added, endometrioses and FOD (Female Organismic Disorder).

Conditions 88

Conditions Advocacy Patients Programs 88

Cannabis Law Report

NOVEMBER 1, 2021

The Transaction is scheduled to close on or about November 15, 2021 , and subject to customary closing conditions and covenants. portfolio and gain access to its product development expertise and formulation lab capabilities. Closing of the Transaction is subject to customary closing conditions and the approval of the CSE.

Research and Development 52

Research and Development Edibles Vaping Seed-To-Sale 52

Cannabis Law Report

JUNE 11, 2021

Total upfront consideration was approximately $240 million, comprised of $45 million in cash and $195 million in Columbia Care stock, with the potential for additional performance-based milestones in 2022 and 2023. Provides home delivery access throughout the state with 10 vehicles.

Dispensary 66

Dispensary Cultivation Research and Development Retail 66

The Joint Blog

AUGUST 8, 2023

As of April 2023, 24 states, including Washington DC, have unintentionally legalized hemp-derived intoxicants, including delta-8 THC, by updating their controlled substance laws to reflect the changes in the 2018 farm bill. However, the legality of delta-8 THC becomes more nuanced when considering state laws.

Cannabinoids 26

Cannabinoids THC Packaging Safety 26

Cannabis Law Report

SEPTEMBER 21, 2022

The impairment charges were triggered by changes in cannabis market conditions, and in the current capital market environment including higher rates of borrowing and lower foreign exchange rates. As of June 30, 2022 , the Company has access to US$713.7 million under the 2021 Shelf Prospectus, including the balance of US$186.2

Research and Development 52

Research and Development Cannabis Data Events 52

Cannabis Law Report

JUNE 1, 2021

Implementation of supply chain optimization well underway with network optimization and complexity reduction initiatives expected to realize our previously stated cost savings of $150 million to $200 million by the end of the first half of FY 2023. A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link].

Data 95

Data Vaping Supply Chain Business 95

Project CBD

MAY 3, 2023

Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. CannMed: For what conditions do you think CBG has the most promise? It can be a very difficult condition. How easy is it to access CBG products?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

NOVEMBER 17, 2021

Additionally, NuLeaf owns a third licensed retail dispensary located directly on Las Vegas Boulevard (the “Las Vegas Strip Dispensary”), expected to become operational in early 2022, subject to regulatory approval and other conditions. 1 Includes an awarded conditional dispensary where Jushi owns 49%. or greater than $7.00

Dispensary 52

Dispensary Wellness and Beauty Retail Cultivation 52

Cannabis Law Report

AUGUST 6, 2021

“We’re continuing to drive cost savings and operational efficiencies across the company, and remain broadly on track to our target of $150 – $200 million in fiscal 2022- fiscal 2023,” added Mike Lee , CFO. “We A replay will be accessible by webcast until 11:59 PM ET on November 4, 2021 at: [link]. Webcast Information.

Vaping 105

Vaping Research and Development Data Business 105

SpeedWeed

MARCH 26, 2021

And while business applications for mushroom health practitioners won’t be accepted until early 2023, one drug education collective is getting a head start on providing fellow Oregonians with the information they need to enter into this brave new era informed.

Therapy 52

Therapy Education Legalization Media 52

Cannabis Law Report

NOVEMBER 9, 2021

million of interest savings in 2022, and these new term loans will effectively extend the amortization period of the Crown Capital facility, which has a “bullet” maturity in May 2023. DCM will be using Microsoft Teams to broadcast the call, which will be accessible via the options below: Join on your computer or mobile app.

Data 52

Data Business Supply Chain Banking 52

Cannabis Law Report

NOVEMBER 9, 2021

Broker network has access to approximately 50,000 convenience stores. An increase in C-stores and inventory turns in existing clients is driving these numbers and we expect single-serves to account for 20-25% of the Company’s sales in fiscal 2023. “A To access the replay, please dial 877-660-6853 in the U.S.

Retail 52

Retail History Supply Chain Food 52

Cannabis Law Report

MARCH 3, 2020

The event sold out with over 180 attendees. The Hemp University’s first educational symposium event of 2018 entitled “Growing Hemp for Profit” took place on Saturday, March 10, 2018. Hemp Money Event: Economics, Lessons & Planning for 2018 – December 2, 2017 – (North Carolina). This was Hemp, Inc.’s

Hemp 59

Hemp Seed-To-Sale Education Research and Development 59

Meadow

DECEMBER 24, 2017

Last not least: thank you to our generous sponsors for making this event possible! So just going overview here, temporary events, that’s the big thing that people have been talking about on the retail side. But in the short term, it only really makes you eligible to apply for a temporary event permit, or license.

Packaging 40

Packaging Retail Edibles Wellness and Beauty 40

Cannabis Law Report

DECEMBER 30, 2019

Now, nearly 1 in 4 Americans reside in a jurisdiction where the adult use of cannabis is legal, and 33 states regulate medical marijuana access. In the existing state-legal regulated marijuana marketplaces, businesses struggle to access basic banking services due to the federal prohibition of marijuana. A Pathway Towards SAFE Banking.

Legislation 59

Legislation Patients Access Banking 59